Key result
MiR-377-3p inhibits hepatocellular carcinoma growth and metastasis by targeting CPT1C to suppress fatty acid oxidation, with high miR-377-3p and low CPT1C expression predicting better overall survival in patients.
Why the study?
Altered lipid metabolism is linked to hepatocellular carcinoma and CPT1C promotes cancer progression, but how microRNAs regulate CPT1C-mediated fatty acid transport and oxidation was unclear.
MiR-377-3p inhibits hepatocellular carcinoma growth and metastasis by negatively regulating CPT1C-mediated fatty acid oxidation, presenting a potential therapeutic target.
BACKGROUND: Altered lipid metabolism is closely related to the occurrence and development of hepatocellular carcinoma (HCC). Carnitine palmitoyltransferase 1C (CPT1C) is a member of CPT1 family and plays a key role in cancer development and progression. However, how microRNAs (miRNAs) regulate CPT1C-mediated fatty acid transport and oxidation remains to be elucidated. METHODS: Oil Red O staining, mitochondrial, and lipid droplets immunofluorescence staining were used to detect the functions of miR-377-3p and CPT1C in fatty acid oxidation. Colocalization of palmitate and mitochondria was performed to investigate the function of miR-377-3p and CPT1C in fatty acid transport into mitochondria. Fatty acid oxidation (FAO) assay was used to detect the function of miR-377-3p and CPT1C in FAO. Cell proliferation, migration and invasion assays and animal experiments were used to evaluate the role of miR-377-3p/CPT1C axis in HCC progression in vitro and in vivo. Immunofluorescence staining was used to identify the clinical significance of miR-377-3p and CPT1C in HCC patients. RESULTS: MiR-377-3p inhibits CPT1C expression by targeting its 3'-untranslated region. Through repression of CPT1C, miR-377-3p suppresses fatty acid oxidation by preventing fatty acid from entering into mitochondria and decreasing ATP production in HCC cells. Inhibiting fatty acid oxidation abolishes the ability of miR-377-3p/CPT1C axis to regulate HCC proliferation, migration, invasion and metastasis in vitro and in vivo. In HCC patients, CPT1C is significantly upregulated, and miR-377-3p expression and lipid droplets are negatively correlated with CPT1C expression. High expression of miR-377-3p and CPT1C predict better and worse clinical outcomes, respectively. CONCLUSIONS: We uncover the key function and the relevant mechanisms of the miR-377-3p/CPT1C axis in HCC, which might provide a potential target for the treatment of HCC.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2022) studied Hepatocellular carcinoma (n=90). miR-377-3p and CPT1C expression vs. Adjacent normal tissues / Low expression was evaluated on Overall survival and tumor growth/metastasis. MiR-377-3p inhibits hepatocellular carcinoma growth and metastasis by targeting CPT1C to suppress fatty acid oxidation, with high miR-377-3p and low CPT1C expression predicting better overall survival in patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: